Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQX - Delayed Quote USD

(NGHLF)

Compare
1.7500
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Loading Chart for NGHLF
  • Previous Close 0.0000
  • Open --
  • Bid 1.3400 x 29200
  • Ask 141.3300 x 41800
  • Day's Range --
  • 52 Week Range 1.7500 - 1.7500
  • Volume --
  • Avg. Volume 0
  • Market Cap (intraday) 250.423M
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.

nightingalehealth.com

94

Full Time Employees

June 30

Fiscal Year Ends

Recent News: NGHLF

View More

Performance Overview: NGHLF

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .

YTD Return

NGHLF
0.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

1-Year Return

NGHLF
0.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

3-Year Return

NGHLF
0.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

5-Year Return

NGHLF
0.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

Compare To: NGHLF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NGHLF

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    196.00M

  • Enterprise Value

    129.90M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -12.91%

  • Return on Equity (ttm)

    -20.65%

  • Revenue (ttm)

    4.95M

  • Net Income Avi to Common (ttm)

    -17.14M

  • Diluted EPS (ttm)

    -0.3300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    59.71M

  • Total Debt/Equity (mrq)

    2.25%

  • Levered Free Cash Flow (ttm)

    -4.83M

Research Analysis: NGHLF

View More

Company Insights: NGHLF

Research Reports: NGHLF

View More